Author:
Hazlehurst Lori A.,Dalton William S.
Reference71 articles.
1. Dalton WS, Salmon SE. Drug resistance in myeloma: mechanisms and approaches to circumvention. Hematol Oncol Clin North Am 1992; 6:383–393.
2. Hazlehurst LA, Foley NE, Gleason-Guzman MC, et al. Multiple mechanisms confer drug-resistance to mitoxantrone in the human 8226 myeloma cll line. Cancer Res 1999; 59:1021–1028.
3. Hazlehurst LA, Enkemann S, Beam CAR, et al. Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model. Cancer Res 2003; 56:660–670.
4. Damiano JS, Cress AE, Hazlehurst LA, Shtil AA, Dalton WS. Cell adhesion mediated drug resistance (CAM-DR): Role of integrins and resistance to apoptosis in human myeloma cell lines. Blood 1999; 93:1658–1667.
5. Hazlehurst LA, Damiano JS, Buyuksalm I, Pledger WJ, Dalton WS. Adhesion to fibronectin regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR). Oncogene 2000; 38:4319–4327.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献